Clin2
NCT06690099Possibly a fitActive, not recruiting

Collecting blood from Rh negative pregnant women

Rhesus D GenotypePregnancy

Part of Women’s health & pregnancy clinical trials.

This study collects a blood sample from pregnant women who are Rh-negative to better understand how to prevent complications in future pregnancies. It does not test any drug or treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are pregnant with a single baby (not twins or more) and are between 12 and 28 weeks along.
  • Your blood type is Rh-negative (checked by a doctor).
  • You are 18 years or older and willing to sign a consent form.
  • You agree to let us test your baby's blood type after birth.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05035160Recruiting
Join a pregnancy tissue and sample study for research

This study collects and stores samples from pregnancy, birth, or after delivery to help researchers learn from perinatal health information. It may help future care by building a high-quality repository of biospecimens and related data.

Los Angeles, California
NCT07566780Not yet recruiting
Non-invasive prenatal screening blood test study

This study tests a new blood test during early pregnancy that can screen for certain genetic conditions by analyzing fetal cells. A simple blood draw may help detect potential chromosomal abnormalities earlier and more safely than traditional methods.

NCT06979492Recruiting· Phase 4
Blood transfusions for pregnant women with sickle cell disease

This study tests whether giving regular blood transfusions during early pregnancy can help prevent complications for women with sickle cell disease. If you are between 6 and 20 weeks pregnant, you may join to see if this treatment improves outcomes.

Atlanta, Georgia
NCT07194070Recruiting
Registry study for hemolytic disease in pregnancy

This study tracks pregnancies affected by hemolytic disease of the fetus and newborn (HDFN). It collects information to better understand the condition and improve care. You may join if you are pregnant with a history of a prior affected pregnancy and have a current antibody that could harm your baby.

Indianapolis, Indiana
NCT06249178Recruiting
Understanding pregnancy health with a blood test

This study tests a new blood test to track how the body responds to treatment during pregnancy, especially for those at risk of high blood pressure conditions. It may help doctors monitor and improve care.

Columbus, Ohio
NCT02543996Recruiting
Providing blood or tissue samples to study disease

This study collects and stores biological samples (like blood and cord blood) to help researchers understand what causes disease. You may be asked to provide samples during pregnancy, delivery, or from an affected person, depending on eligibility.

Bethesda, Maryland

Hear when a new Pregnancy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.